LONDON: The Oxford/AstraZeneca vaccine fails to prevent mild and moderate cases of the South African coronavirus strain, according to research reported in the Financial Times.But in its study, due to be published Monday, the pharma group said it could still have an effect on severe disease -- although there is not yet enough data to make a definitive judgement.None of the 2,000 participants in the trial developed serious symptoms, the FT said, but AstraZeneca said the sample size was too small to make a full determination."We may not be reducing the total number of cases but there is still protection against deaths, hospitalisations and severe disease," said Sarah Gilbert, who led the development of the vaccine with the Oxford Vaccine Group.It could also be "some time" before they determine its effectiveness for older people in fighting the strain, which is a growing presence in Britain, she told BBC television."We might have to put it together from a number of studies," she ... » Learn More about AstraZeneca Covid jab ‘less effective against South African strain’: Study
Saiko gilbert
AstraZeneca vaccine being tweaked to fight South Africa variant
For Quick Alerts Subscribe Now Uttarakhand flood: Macron expresses solidarity; US wishes for a speedy recovery of injured View Sample For Quick Alerts ALLOW NOTIFICATIONS For Daily Alerts #Corona Vaccine Oxford/AstraZeneca jab effective against UK Covid variant, study finds #Corona Vaccine Covid-19: Vaccine second dose for beneficiaries on February 13 #Corona Vaccine India developing 7 more COVID vaccines: Harsh Vardhan #Corona Vaccine Over 54 lakh vaccinated against COVID-19 #Corona Vaccine 25 countries in queue for 'Made in India' COVID-19 vaccine: EAM S Jaishankar #Corona Vaccine Coronavirus vaccine: Mexico gets Sinovac vaccine paperwork for approval Just In 3 hrs ago Uttarakhand flood: Macron expresses solidarity; US wishes for a speedy recovery of injured 3 hrs ago Dhauli Ganga river's water level at Joshimath breached all records after glacial burst 4 hrs ago TRS meet: No change of guard in Telangana, clarifies ... » Learn More about AstraZeneca vaccine being tweaked to fight South Africa variant
Coronavirus | ‘Oxford vaccine less effective against South African variant’
The Oxford/AstraZeneca vaccine fails to prevent mild and moderate cases of the South African coronavirus strain, according to research reported in the Financial Times.But in its study, due to be published on Monday, the pharma group said it could still have an effect on severe disease — although there is not yet enough data to make a definitive judgment.None of the 2,000 participants in the trial developed serious symptoms, the FT said, but AstraZeneca said the sample size was too small to make a full determination.“We may not be reducing the total number of cases but there is still protection against deaths, hospitalisations and severe disease,” said Sarah Gilbert, who led the development of the vaccine with the Oxford Vaccine Group.It could also be “some time” before they determine its effectiveness for older people in fighting the strain, which is a growing presence in U.K., she said.Researchers are currently working to update the vaccine, and ... » Learn More about Coronavirus | ‘Oxford vaccine less effective against South African variant’
